Reducing risk in transitions of care

Post-acute facilities face numerous challenges, including the prevention of healthcare-acquired infections (HAIs). As facilities receive more medically complex patients from acute settings, there is a greater potential for pathogen transmission. Additionally, hospitals facing penalties for readmissions are reluctant to continue making referrals to facilities that have high rates of serious infections.

The Centers for Medicare and Medicaid Services (CMS) is placing a strong emphasis on preventing healthcare-acquired infections. Beginning in November 2019, CMS will require all federally supported skilled nursing facilities to have a trained infection preventionist on staff.

HAIs are also a problem at nursing homes, where:

  • The rate of methicillin-resistant Staphylococcus aureus (MRSAI) colonization among nursing home residents may exceed 50%1
  • In the last 10 years, colonization with C. difficile (CDI) among nursing home residents ranged from 4% to 50%1

Hibiclens – proven effective

For more than 40 years, hospitals and healthcare systems have relied on Hibiclens antiseptic skin cleanser. Routine washing with Hibiclens delivers proven protection against germs that cause healthcare-associated infections.2 Clinical studies have shown that a 4% chlorhexidine gluconate (CHG) solution, such as Hibiclens, can help reduce facility infection rates.2

One study at Mayo Clinic resulted in a significant reduction in superficial surgical site infections (SSIs) from 4.9% to 1.5% using Hibiclens as part of an SSI reduction bundle including a superficial SSI decrease from 4.9% to 1.6%.3 Another study showed that CHG bathing resulted in a 70% decline in CDIs.2

Mölnlycke helps to make it easy for post-acute care providers – including home health, skilled nursing homes, rehabilitation centers, post-acute care facilities and hospice – to implement an infection control plan. The gentle Hibiclens cleanser with 4% CHG is available in several sizes and formulations and is readily available through retail outlets so it can be used by patients across the continuum of care.

Partnering with Mölnlycke to reduce infection

Mölnlycke SSI prevention support program includes:

  • Staff education and training
  • Tools to measure success
  • Help in identifying internal champions
  • Patient education/instruction tools
  • Compliance resources

If you would like to learn more about Hibiclens or the Hibiclens Compliance Toolkit, contact us at hibibathing@molnlycke.com.

  1. Challenges and Strategies for Prevention of Multidrug-Resistant Organism Transmission in Nursing homes, Ghinwa Dumyait, et al, Current Infect Dis Rep, 2017
  2. Rupp, Mark E. et al. Hospital-Wide Chlorhexidine Patient Bathing Project. University of Nebraska Medical Center 2010. Poster presented at 2010 SHEA Annual Scientific Meeting
  3. Robert Cima, MD, Eugene Dankbar, MS et al. Colorectal Surgery Surgical Site Infection Reduction Program: A National Surgical Quality Improvement Program Driven Multidisciplinary Single-Institution Experience, J Am College Surgery, Vol. 216, No. 1, January 2013